Camp4 Therapeutics Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CAMP Nasdaq 2830 www.camp4tx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Camp4 Therapeutics Corporation

CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 13th, 2025 1:00 pm
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones - Jan 7th, 2025 9:05 pm
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors - Dec 10th, 2024 1:00 pm
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference - Dec 2nd, 2024 1:00 pm
CAMP4 Reports Third Quarter 2024 Financial Results - Nov 21st, 2024 9:05 pm
CAMP4 Announces Pricing of Initial Public Offering - Oct 10th, 2024 11:07 pm
CalAmp Files Bankruptcy to Complete Debt Restructuring - Jun 3rd, 2024 2:01 pm
CalAmp Reaches Comprehensive Agreement to Significantly Reduce Debt, Go Private, and Strengthen Financial Flexibility to Support Innovation Through a Consensual Financial Restructuring - Jun 3rd, 2024 1:25 pm
CalAmp Enhances School Bus Solutions Suite with Dispatch Monitor - May 1st, 2024 8:35 pm
CalAmp Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Feb 28th, 2024 2:22 am